ArticleTanaffos2023

Trimetazidine May Potentially Confer Neuroprotective Effects against COVID-19-Induced Neurological Sequelae via Inhibition of Death-Associated Protein Kinase 1 (DAPK1) Signaling Pathways: An Evidenced-Based Hypothesis.

Ali Aghajani et al.PubMed ↗Full text ↗

No numbers read from the abstract.